Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Efficacy of oritavancin alone and in combination against vancomycin-susceptible and -resistant enterococci in an in-vivo Galleria mellonella survival model.

Meyer KA, Deraedt MF, Harrington AT, Danziger LH, Wenzler E.

Int J Antimicrob Agents. 2019 Aug;54(2):197-201. doi: 10.1016/j.ijantimicag.2019.04.010. Epub 2019 Apr 26.

PMID:
31034937
2.

In vitro activity of oritavancin alone or in combination against vancomycin-susceptible and -resistant enterococci.

Wu T, Meyer K, Harrington AT, Danziger LH, Wenzler E.

J Antimicrob Chemother. 2019 May 1;74(5):1300-1305. doi: 10.1093/jac/dkz010.

PMID:
30753495
3.

Performance of ceftazidime/avibactam susceptibility testing methods against clinically relevant Gram-negative organisms.

Wenzler E, Lee M, Wu TJ, Meyer KA, Shields RK, Nguyen MH, Clancy CJ, Humphries RM, Harrington AT.

J Antimicrob Chemother. 2019 Mar 1;74(3):633-638. doi: 10.1093/jac/dky483.

4.

Improved growth and developmental activity post tracheostomy in preterm infants with severe BPD.

Luo J, Shepard S, Nilan K, Wood A, Monk HM, Jensen EA, Harrington AT, Maschhoff K, Kirpalani H, Feng Z, Zhang H.

Pediatr Pulmonol. 2018 Sep;53(9):1237-1244. doi: 10.1002/ppul.24087. Epub 2018 Jul 3.

5.

Recovery of Cryptococcus gattii from an Infected Ventriculo-Peritoneal Shunt, Illinois, USA.

Moritz D, Mena Lora A, Blumer B, Harrington AT.

Emerg Infect Dis. 2018 Jul;24(7):1382-1383. doi: 10.3201/eid2407.171754.

6.

Clinical evaluation of Roche COBAS® AmpliPrep/COBAS® TaqMan® CMV test using nonplasma samples.

Hildenbrand C, Wedekind L, Li G, vonRentzell JE, Shah K, Rooney P, Harrington AT, Zhao RY.

J Med Virol. 2018 Oct;90(10):1611-1619. doi: 10.1002/jmv.25226. Epub 2018 Jun 12.

PMID:
29797374
7.

Longitudinal timed function tests in Duchenne muscular dystrophy: ImagingDMD cohort natural history.

Arora H, Willcocks RJ, Lott DJ, Harrington AT, Senesac CR, Zilke KL, Daniels MJ, Xu D, Tennekoon GI, Finanger EL, Russman BS, Finkel RS, Triplett WT, Byrne BJ, Walter GA, Sweeney HL, Vandenborne K.

Muscle Nerve. 2018 Nov;58(5):631-638. doi: 10.1002/mus.26161. Epub 2018 Jul 24.

8.

Skeletal muscle magnetic resonance biomarkers correlate with function and sentinel events in Duchenne muscular dystrophy.

Barnard AM, Willcocks RJ, Finanger EL, Daniels MJ, Triplett WT, Rooney WD, Lott DJ, Forbes SC, Wang DJ, Senesac CR, Harrington AT, Finkel RS, Russman BS, Byrne BJ, Tennekoon GI, Walter GA, Sweeney HL, Vandenborne K.

PLoS One. 2018 Mar 19;13(3):e0194283. doi: 10.1371/journal.pone.0194283. eCollection 2018.

9.

Impact of Clinical and Laboratory Standards Institute breakpoint changes on susceptibility rates of cephalosporins in uncomplicated urinary tract infections caused by Enterobacteriaceae.

Bunnell KL, Wenzler E, Harrington AT, Danziger LH.

Diagn Microbiol Infect Dis. 2018 Apr;90(4):335-336. doi: 10.1016/j.diagmicrobio.2017.12.007. Epub 2017 Dec 16.

PMID:
29395714
10.

Multicenter Evaluation of the Accelerate PhenoTest BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular Analysis.

Pancholi P, Carroll KC, Buchan BW, Chan RC, Dhiman N, Ford B, Granato PA, Harrington AT, Hernandez DR, Humphries RM, Jindra MR, Ledeboer NA, Miller SA, Mochon AB, Morgan MA, Patel R, Schreckenberger PC, Stamper PD, Simner PJ, Tucci NE, Zimmerman C, Wolk DM.

J Clin Microbiol. 2018 Mar 26;56(4). pii: e01329-17. doi: 10.1128/JCM.01329-17. Print 2018 Apr.

11.

Deep brain stimulator infection by a novel rapid growing mycobacterium.

Moritz DC, Harrington AT, Slavin K, Gomez C, Jarrett OD.

Acta Neurochir (Wien). 2017 Nov;159(11):2239-2241. doi: 10.1007/s00701-017-3335-5. Epub 2017 Sep 20.

PMID:
28933015
12.

Synergistic activity of ceftazidime-avibactam and aztreonam against serine and metallo-β-lactamase-producing gram-negative pathogens.

Wenzler E, Deraedt MF, Harrington AT, Danizger LH.

Diagn Microbiol Infect Dis. 2017 Aug;88(4):352-354. doi: 10.1016/j.diagmicrobio.2017.05.009. Epub 2017 May 18.

PMID:
28602518
13.

Pasteurella multocida urinary tract infection in a patient with cervical cancer.

Singh MB, Harrington AT.

JMM Case Rep. 2017 Jan 31;4(1):e005082. doi: 10.1099/jmmcr.0.005082. eCollection 2017 Jan.

14.

Passive range of motion exercise to enhance growth in infants following the Norwood procedure: a safety and feasibility trial.

Lambert LM, Trachtenberg FL, Pemberton VL, Wood J, Andreas S, Schlosser R, Barnard T, Daniels K, Harrington AT, Dagincourt N, Miller TA; Pediatric Heart Network Investigators.

Cardiol Young. 2017 Sep;27(7):1361-1368. doi: 10.1017/S1047951117000427. Epub 2017 Mar 23.

15.

Cutaneous Nocardiosis: A Conspicuous Eyelid Eschar.

Lake EP, Hughart R, Jones ST, Kreppel A, Tsoukas M, Harrington AT.

J Pediatr. 2016 Oct;177:327. doi: 10.1016/j.jpeds.2016.06.084. Epub 2016 Aug 2. No abstract available.

PMID:
27496269
16.

Multicenter prospective longitudinal study of magnetic resonance biomarkers in a large duchenne muscular dystrophy cohort.

Willcocks RJ, Rooney WD, Triplett WT, Forbes SC, Lott DJ, Senesac CR, Daniels MJ, Wang DJ, Harrington AT, Tennekoon GI, Russman BS, Finanger EL, Byrne BJ, Finkel RS, Walter GA, Sweeney HL, Vandenborne K.

Ann Neurol. 2016 Apr;79(4):535-47. doi: 10.1002/ana.24599. Epub 2016 Feb 19.

17.
18.

Implementing treatment frequency and duration guidelines in a hospital-based pediatric outpatient setting: administrative case report.

Hanson H, Harrington AT, Nixon-Cave K.

Phys Ther. 2015 Apr;95(4):678-84. doi: 10.2522/ptj.20130360. Epub 2015 Jan 8.

PMID:
25573762
19.

Impact of identification of Streptococcus dysgalactiae subspecies equisimilis from throat cultures in an adult population.

Harrington AT, Clarridge JE 3rd.

Diagn Microbiol Infect Dis. 2013 May;76(1):20-3. doi: 10.1016/j.diagmicrobio.2013.02.029. Epub 2013 Mar 26.

PMID:
23537788
20.

Impact of strain typing methods on assessment of relationship between paired nares and wound isolates of methicillin-resistant Staphylococcus aureus.

Clarridge JE 3rd, Harrington AT, Roberts MC, Soge OO, Maquelin K.

J Clin Microbiol. 2013 Jan;51(1):224-31. doi: 10.1128/JCM.02423-12. Epub 2012 Nov 7.

21.

Evaluation of functional electrical stimulation to assist cycling in four adolescents with spastic cerebral palsy.

Harrington AT, McRae CG, Lee SC.

Int J Pediatr. 2012;2012:504387. doi: 10.1155/2012/504387. Epub 2012 May 22.

22.

A lingual abscess caused by Streptococcus intermedius.

Harrington AT, Hsia JC, Mendez E, Clarridge JE 3rd.

J Med Microbiol. 2012 Apr;61(Pt 4):590-2. doi: 10.1099/jmm.0.036913-0. Epub 2011 Nov 24.

PMID:
22116986
23.
24.

Isolation of Bordetella avium and novel Bordetella strain from patients with respiratory disease.

Harrington AT, Castellanos JA, Ziedalski TM, Clarridge JE 3rd, Cookson BT.

Emerg Infect Dis. 2009 Jan;15(1):72-4. doi: 10.3201/eid1501.071677.

25.

Diagnosis of neurocysticercosis by detection of Taenia solium DNA using a global DNA screening platform.

Harrington AT, Creutzfeldt CJ, Sengupta DJ, Hoogestraat DR, Zunt JR, Cookson BT.

Clin Infect Dis. 2009 Jan 1;48(1):86-90. doi: 10.1086/594128.

26.

Preparation and characterization of translocator/chaperone complexes and their component proteins from Shigella flexneri.

Birket SE, Harrington AT, Espina M, Smith ND, Terry CM, Darboe N, Markham AP, Middaugh CR, Picking WL, Picking WD.

Biochemistry. 2007 Jul 10;46(27):8128-37. Epub 2007 Jun 16.

PMID:
17571858
27.

IpaD of Shigella flexneri is independently required for regulation of Ipa protein secretion and efficient insertion of IpaB and IpaC into host membranes.

Picking WL, Nishioka H, Hearn PD, Baxter MA, Harrington AT, Blocker A, Picking WD.

Infect Immun. 2005 Mar;73(3):1432-40.

28.

Structural characterization of the N terminus of IpaC from Shigella flexneri.

Harrington AT, Hearn PD, Picking WL, Barker JR, Wessel A, Picking WD.

Infect Immun. 2003 Mar;71(3):1255-64.

Supplemental Content

Loading ...
Support Center